VANCOUVER, BC , April 5, 2024 /CNW/ - Asep Medical Holdings Inc. ("Asep" or the "Company") (CSE: ASEP) (OTCQB: SEPSF) (FSE: JJ8) is very pleased to announce that its joint venture company with leading Chinese biotech company Sansure Biotech Inc. (" Sansure "), Hunan Sanway SepSMART Ltd. (" SepSMART "), which is based in Changsha, China , has obtained its business license and is now formally registered in China , which marks... Read More

CLICK HERE TO REGISTER VANCOUVER, BC , March 18, 2024 /CNW/ - Asep Medical Holdings Inc. ("Asep Inc." or the "Company") (CSE: ASEP) (OTCQB: SEPSF) (FSE: JJ8) is pleased to announce that it is holding an online webinar on March 22, 2024 , at 4:00 pm EST to provide significant updates on the company's latest milestones. Investors, potential investors, analysts, and members of the medical community are invited to register for... Read More

VANCOUVER, BC , March 13, 2024 /CNW/ - In a recent presentation to the US Biophysical Society in Philadelphia 1 , Asep Medical Holdings Inc. ("Asep Inc." or the "Company") (CSE: ASEP) (OTCQB: SEPSF) (FSE: JJ8) CEO Dr. Bob Hancock announced how the ground-breaking use of artificial intelligence (AI) has allowed the development of new and improved treatments for biofilm infections. Biofilms are communities of bacteria that... Read More

VANCOUVER, BC , Feb. 27, 2024 /CNW/ - Asep Medical Holdings Inc. (" Asep Inc. " or the " Company ") (CSE: ASEP) (OTCQB: SEPSF) (FSE: JJ8) is pleased to announce that its proprietary gene expression signature for sepsis can provide an improved assessment of the severity of appendicitis in children. According to Dr. Rob Stenstrom , Asep's Medical Director, "Abdominal pain is one of the most common complaints we see for... Read More

VANCOUVER, BC , Dec. 28, 2023 /CNW/ - Asep Medical Holdings Inc. (" Asep Inc. " or the " Company ") (CSE: ASEP) (OTCQB: SEPSF) (FSE: JJ8) is pleased to announce that, further to its news release of December 18, 2023 , it has issued 3,915,930 units (each, a " Unit ") of the Company at a deemed price of $0.20 per Unit in settlement of an aggregate of $783,186 comprised of $421,000 for past services performed for the Company by... Read More

VANCOUVER, BC , Dec. 20, 2023 /CNW/ - Asep Medical Holdings Inc. (" Asep Inc. " or the " Company ") (CSE: ASEP) (OTCQB: SEPSF) (FSE: JJ8) is pleased to announce that, further to its news release of December 18, 2023 which announced a private placement and debt settlement of up to 10,000,000 units of the Company (each, a " Unit ") pursuant to the listed issuer financing exemption (" LIFE Exemption ") for gross proceeds of up... Read More

/NOT FOR DISTRIBUTION TO U.S. NEWSWIRE SERVICES OR FOR DISSEMINATION IN THE UNITED STATES / VANCOUVER, BC , Dec. 18, 2023 /CNW/ - Asep Medical Holdings Inc. (" Asep Inc. " or the " Company ") (CSE: ASEP) (OTCQB: SEPSF) announces availability of a $500,000 credit facility from an arm's length lender, settlement of an aggregate of $783,186 of debt to certain creditors and certain amendments to the offering document previously... Read More

VANCOUVER, BC , Nov. 30, 2023 /CNW/ - Asep Medical Holdings Inc. (" Asep Inc. " or the " Company ") (CSE: ASEP) (OTCQB: SEPSF) is pleased to announce a non-brokered private placement of up to 10,000,000 units of the Company (each, a " Unit ") at a price of $0.20 per Unit, for aggregate gross proceeds of up to $2,000,000 (the " Offering "). Each Unit will consist of one (1) common share in the capital of the Company (each, a... Read More

VANCOUVER, BC , Nov. 24, 2023 /CNW/ - Asep Medical Holdings Inc. (" Asep Inc. " or the " Company ") (CSE: ASEP) (OTCQB: SEPSF) (FSE: JJ8) is pleased to announce that the Company's AI-based sepsis diagnostic technology, called Sepset ER TM , has received successful patent approval in the United States . The Company received confirmation from its attorneys of its US Patent Application No. 16/279788, which has been subsequently... Read More

VANCOUVER, BC , Nov. 21, 2023 /CNW/ - Asep Medical Holdings Inc. ("Asep" or the "Company") (CSE: ASEP) (OTCQB: SEPSF) (FSE: JJ8) is very pleased to announce that, through its subsidiary Sepset Biosciences Inc. (" Sepset "), it has signed a definitive joint venture agreement (the " JV Agreement ") with leading Chinese medical... Read More

VANCOUVER, BC , Nov. 17, 2023 /CNW/ - Asep Medical Holdings Inc. ("Asep Inc." or the "Company") (CSE: ASEP) (OTCQB: SEPSF) (FSE: JJ8) is pleased to announce it is in the final stage of its approval process for the draft registration statement on Form F-1 which was filed with the U.S. Securities and Exchange Commission (the "SEC") for its planned listing and trading of common shares on the NASDAQ stock exchange. The document... Read More

VANCOUVER, BC , July 31, 2023 /CNW/ - Asep Medical Holdings Inc. (" Asep Inc. " or the " Company ") (CSE: ASEP) (OTCQB: SEPSF) (FSE: JJ8) is pleased to announce that, as of July 21, 2023 , it has completed the final milestone in its acquisition of SafeCoat Medical Inc. (" SafeCoat ") and entered into an exclusive worldwide license agreement (the " Agreement ") with the University of British Columbia (" UBC "), through its... Read More

A recent study led by Asep Inc.'s Founder, Chair and CEO, Dr. Robert E. W. Hancock , concludes that there is hope for improved clinical management of COVID-19 patients by better assessing the severity of sepsis, a deadly disease that impacts many COVID-19 patients. VANCOUVER, BC , July 14, 2023 /CNW/ - Asep Medical Holdings Inc. ("Asep Inc." or the "Company") (CSE: ASEP) (OTCQB: SEPSF) (FSE: JJ8) is pleased to announce the... Read More

VANCOUVER, BC , July 7, 2023 /CNW/ - Asep Medical Holdings Inc. (" Asep Inc. " or the " Company ") (CSE: ASEP) (OTCQB: SEPSF) is pleased to announce that it held its Annual General Meeting of Shareholders (the " Meeting ") on Friday, June 30, 2023 . AGM Results All of the motions proposed in the Notice of Annual General Meeting dated May 31, 2023 , which was filed on SEDAR together with the Management's Information Circular... Read More

VANCOUVER, BC , July 3, 2023 /CNW/ - Asep Medical Holdings Inc. ("Asep Inc." or the "Company") (CSE: ASEP) (OTCQB: SEPSF) (FSE: JJ8) is pleased to announce it has formally filed a confidential draft registration statement on Form F-1 to the U.S. Securities and Exchange Commission (the "SEC") for its planned listing and trading of common shares on the NASDAQ stock exchange. The document was submitted by Asep Inc.'s New York... Read More

The New Grant Will Support Important Pre-clinical Studies VANCOUVER, BC , June 23, 2023 /CNW/ - Asep Medical Holdings Inc. ("Asep Inc." or the "Company") (CSE: ASEP) (OTCQB: SEPSF) (FSE: JJ8) is pleased to announce, along with their academic partners at the University of British Columbia (UBC), that they have been awarded a grant from the NanoMedicines Innovation Network (NMIN) to investigate further and identify an optimal... Read More

VANCOUVER, BC , June 20, 2023 /CNW/ - Asep Medical Holdings Inc. ("Asep Inc." or the "Company") (CSE: ASEP) (OTCQB: SEPSF) (FSE: JJ8) is delighted to announce that the Company's Founder, Chair and CEO has recently been ranked as the 4 th Best Microbiologist in the World (1 st in Canada ) according to www.research.com , a leading scientific research portal based in Southampton, England . The rankings are based on the D-index... Read More

VANCOUVER, BC , June 16, 2023 /CNW/ - Asep Medical Holdings Inc. ("Asep Inc." or the "Company") (CSE: ASEP) (OTCQB: SEPSF) (FSE: JJ8) is very pleased to announce it is preparing the final draft of its NASDAQ registration statement for its planned listing and trading of its common shares on the NASDAQ stock exchange. The Company has engaged New York -based law firm Sichenzia Ross Ference LLP to take the lead with the... Read More

VANCOUVER, BC , June 9, 2023 /CNW/ - Pursuant to the signing of a Letter of Intent (LOI) in December 2022 , Asep Medical Holdings Inc. ("Asep Inc." or the "Company") (CSE: ASEP) (OTCQB: SEPSF) (FSE: JJ8) is delighted to announce it has signed a definitive agreement ("agreement") for a joint venture with Bahrain -based... Read More

VANCOUVER, BC , June 2, 2023 /CNW/ - Asep Medical Holdings Inc. ("Asep Inc." or the "Company") (CSE: ASEP) (OTCQB: SEPSF) (FSE: JJ8) announces the ground-breaking use of artificial intelligence (AI) to rapidly identify infections at increased risk of severe sepsis. The method was developed by the Hancock Lab, under the guidance of Dr. Robert E.W. Hancock , Killam Professor at the University of British Columbia (UBC), and... Read More

VANCOUVER, BC , May 30, 2023 /CNW/ - Asep Medical Holdings Inc. ("Asep Inc." or the "Company") (CSE: ASEP) (OTCQB: SEPSF) (FSE: JJ8) is very pleased to announce that it has engaged Aegis Capital Corporation ("Aegis"), a New York -based investment bank, as underwriter agent for a proposed listing on the NASDAQ Stock Exchange (the "Offering"). The Offering is expected to consist of a sale of the minimum requirement needed to... Read More

VANCOUVER, BC , March 6, 2023 /CNW/ - Asep Medical Holdings Inc. ("Asep Inc." or the "Company") (CSE: ASEP) (OTCQB: SEPSF) (FSE: JJ8) is delighted to announce the appointments of five new members to its advisory board, all of which take effect immediately and the appointment of Dr. Rob Stenstrom , as Medical Director, effective February 24, 2023 . The Company also announces the grant of stock options and restricted share... Read More

VANCOUVER, BC , Jan. 27, 2023 /CNW/ - Asep Medical Holdings Inc. ("Asep Inc." or the "Company") (CSE: ASEP) (OTCQB: SEPSF) is pleased to announce that it has signed a joint venture term sheet with a leading Chinese medical diagnostic company, Sansure Biotech Inc. (Sansure). The term sheet was signed on September 29, 2022 . Both parties will continue to negotiate the specific collaboration terms toward the goal of entering... Read More

VANCOUVER, BC , Jan. 20, 2023 /CNW/ - Asep Medical Holdings Inc. (" Asep Inc. " or the " Company ") (CSE: ASEP) (OTCQB: SEPSF) (FSE: JJ8) is pleased to announce that the directors have adopted a long-term performance incentive plan (the " Plan "), whereby the Company may grant restricted share units, performance share units or deferred share units (collectively, the " Awards "). The total common shares of the Company (each,... Read More

Webinar Features Strategic Insights from Asep Inc.'s Senior Executives, including Founder and CEO Dr. Robert E. W. Hancock , CSO Dr. Evan Haney and COO Mr. Timothy Murphy VANCOUVER, BC , Jan. 18, 2023 /CNW/ - Asep Medical Holdings Inc. ("Asep Inc." or the "Company") (CSE: ASEP) (OTCQB: SEPSF) (FSE: JJ8) is pleased to announce that it is holding an online webinar on January 24, 2023 , at 1:00 pm EST to provide essential and... Read More

VANCOUVER, BC , Jan. 6, 2023 /CNW/ - Asep Medical Holdings Inc. ("Asep Inc." or the "Company") (CSE: ASEP) (OTCQB: SEPSF) (FSE: JJ8) is delighted to announce the recent signing of a Letter of Intent (LOI) for a joint venture between Asep Inc. and Seaspring W.L.L. (Seaspring), a Bahrain -based international investment consultancy firm. The joint venture will be owned 50/50 between Asep Inc. and Seaspring pursuant to a... Read More

VANCOUVER, BC , Dec. 28, 2022 /CNW/ - Asep Medical Holdings Inc. ("Asep Inc." or the "Company") (CSE: ASEP) (OTCQB: SEPSF) (FSE: JJ8) at the request of IIROC the Company would like to provide clarification on the disclosure regarding the diagnostic and therapeutic technologies of the Company and its subsidiaries Sepset Biosciences Inc. ("Sepset") and ABT Innovations Inc. ("ABT") that was included in a news release dated... Read More

VANCOUVER, BC , Dec. 23, 2022 /CNW/ - Asep Medical Holdings Inc. ("Asep Inc." or the "Company") (CSE: ASEP) (OTCQB: SEPSF) (FSE: JJ8) is pleased to announce that, through its subsidiaries Sepset Biosciences Inc. (" Sepset ") and ABT Innovations Inc. ( "ABT" ), the Company is addressing antibiotic failure on two fronts — a novel diagnostic assay that detects severe sepsis in the emergency room (ER), and a peptide technology... Read More

VANCOUVER, BC , Nov. 24, 2022 /CNW/ - Asep Medical Holdings Inc. (" Asep Inc. " or the " Company ") (CSE: ASEP) (OTCQB: SEPSF) (FSE: JJ8) is pleased to announce that, for recruitment, incentivization and retention purposes, it has granted to certain officers and advisors an aggregate of 1,080,000 stock options (the " Options ") to purchase up to 1,080,000 common shares (each, a " Share ") of the Company of which 200,000 are... Read More